Once research has shown it is safe to do so, human embryos, sperm and eggs could all be genetically manipulated to mend faulty genes which are known to cause serious disease or disability. Photograph: TEK image/Getty Images/Science Photo Library RF
Powerful gene editing procedures could one day be allowed to prevent people from passing on serious medical conditions to their children, according to a major report from senior US researchers.
The cautious endorsement from two of the most prestigious US science institutions means that human embryos, sperm and eggs could all be genetically manipulated to mend faulty genes which are known to cause serious disease or disability, once research has shown it is safe to do so.
The report from the National Academy of Sciences and the National Academy of Medicine says the procedure is highly contentious because any genetic changes that are made are then inherited by the next generation. The technology would therefore cross a line many have viewed as ethically inviolable, it states.
Most scientists agree that far more work is needed before clinical trials of so-called germline therapies can begin in humans. But the report argues that if the procedure is found to be safe and effective in the years ahead, it should not be ruled out in exceptional cases.
We have identified a very strict set of criteria which, if satisfied, could make it permissible to start clinical trials, said Alta Charo, co-chair of the report committee and professor of law and bioethics at the University of WisconsinMadison. While gene editing is unlikely to affect the prevalence of diseases any time soon, it could provide some families with their best hope for having healthy children.
According to the report, human embryos, sperm and eggs should only be considered for gene editing to prevent serious conditions and when no other alternative is available. To go ahead, scientists would have to be confident they could stop a disorder by rewriting the DNA in a faulty gene to make it into a healthy version already found in the population.
The report stresses the need for a stringent oversight system for any such trials to make sure scientists, patients and the broader public understand the risks and benefits, and to come down hard on any clinics that offer treatment for less serious disorders or for human enhancement.
There is an enormous amount of research that has to go into this, and then the question is what are the conditions where youd even consider it, and those are very tightly defined, said Rudolf Jaenisch, a member of the report committee and professor of biology at MIT. It would be conditions where no other options exist to have a healthy baby.
One example is when an adult carries two copies rather than one of the gene that causes Huntingtons disease, a devastating condition that steadily damages nerves in the brain. If that person has children they will inherit at least one copy and will develop the disease. With gene editing, harmful copies could potentially be fixed in the parents sperm or eggs, or in any embryos created through IVF.
Under British law, gene edited embryos, or embryos made with genetically engineered sperm or eggs, cannot be implanted into a woman. The only exception, endorsed by parliament in 2015, is for a procedure called mitochondrial transfer, which aims to prevent women from passing on genetic diseases to their children. In the US, the Food and Drug Administration is currently not allowed to consider applications for germline therapy clinical trials, but the temporary restriction is only in place until April this year.
The national academies report comes at a time when scientists are making spectacular progress in genome editing. With the latest gene editing tool, named Crispr-cas9, scientists can alter single letters of the DNA code, or rewrite whole genes. The technique has given researchers unprecedented insights into the basic biology of development and cancer, but has also been tested in animals as a treatment for a wide range of diseases. Last year, a Chinese group became the first to launch a trial of Crispr-cas9 to treat patients with aggressive lung cancer for whom all other therapies had failed.
In separate research published in Nature Communications on Wednesday, scientists at the University of Washington in Seattle used gene editing to rewrite faulty genes responsible for Duchenne muscular dystrophy in adult mice. Were a long way from clinical application but theres no doubt that the results of this study are exciting, said Darren Griffin, a geneticist at the University of Kent. Other studies reporting progress with different diseases emerge at least every month.
The national academies report goes on to back the use of genome editing to correct faulty genes in adult tissues, such as the liver, lungs and heart, where the changes will not be passed on to children. But while it recommends that the tool is used only to prevent and treat diseases and disabilities, the report points out that in the future, the same interventions could potentially enhance peoples natural abilities. For example, a gene editing therapy that boosts the muscles of patients with muscular dystrophy could perhaps be given to healthy people to give them superhuman strength. We need an ongoing public conversation about how much value we place on some of these so-called enhancements, said Charo. Until we know that, we cant know how to value them against the risks.
Even the academies heavily-caveated endorsement of gene editing will raise fears of a slippery slope that leads to a society of genetic haves and have-nots. But Richard Hynes, a report chair and cancer researcher at MIT, said that regulations could effectively block the use of the tools for enhancement. The slope is not very slippery. Friction is introduced by the regulatory system, he said.
Charo ruled out the use of gene editing to boost peoples intelligence, which is thought to be influenced by hundreds, if not thousands, of genes. We have no idea how to define intelligence, let alone how to manipulate it genetically, Charo said. Its one of the examples that is raised all the time, but its one of the least likely to be relevant, because we dont have a clue how wed do that.
Read the rest here:
Major report prepares ground for genetic modification of human embryos - The Guardian
- June 11th At Westport, CT: Federal Red Flags, HIPAA Security Rules and Fraud Prevention - November 7th, 2009 [November 7th, 2009]
- Do not learn Dvorak! - November 7th, 2009 [November 7th, 2009]
- You Can’t Solve Problems By Making It Illegal To Have The Problem - November 7th, 2009 [November 7th, 2009]
- A Force Fix for Healthcare - November 7th, 2009 [November 7th, 2009]
- Yahble, HIT, Bubblecon, BIZDEV!, Solid State - November 7th, 2009 [November 7th, 2009]
- 15 things that suck about the Palm Pre - November 7th, 2009 [November 7th, 2009]
- What an Indie Genomics Lab Looks Like - November 7th, 2009 [November 7th, 2009]
- Practice Fusion: Class D Felony? - February 26th, 2010 [February 26th, 2010]
- Practice Fusion Responds - March 7th, 2010 [March 7th, 2010]
- Practice Fusion: Do the math: $44,000 is a LIE - March 10th, 2010 [March 10th, 2010]
- How Much Until Doctors Approve of 23andMe? - March 10th, 2010 [March 10th, 2010]
- Biochemicals as Media, Not Methods - March 10th, 2010 [March 10th, 2010]
- More Practice Fusion Reality Distortion - March 10th, 2010 [March 10th, 2010]
- Same Test Results: 23andMe is Myriad is BRCA is Medicine - March 12th, 2010 [March 12th, 2010]
- BRCA is 23andMe is Myriad is Medicine - March 13th, 2010 [March 13th, 2010]
- Getting Serious About Genomics as Common Medical Practice - March 15th, 2010 [March 15th, 2010]
- The New John Mackey of Genetics: Linda Avey? - March 15th, 2010 [March 15th, 2010]
- Keep the Medical, Well, Medical - March 16th, 2010 [March 16th, 2010]
- If 23andMe shuts down, it won’t be for some mundane reason like the bills weren’t paid - March 16th, 2010 [March 16th, 2010]
- If I Run A Medical Practice, How Do I Use A 23andMe? - March 17th, 2010 [March 17th, 2010]
- 23andMe Contract in Bad Faith - March 19th, 2010 [March 19th, 2010]
- Doctors CANNOT Use 23andMe Due To 23andMe’s Bad Faith Contract - March 20th, 2010 [March 20th, 2010]
- Pathway Compared to 23andMe and Navigenics - March 22nd, 2010 [March 22nd, 2010]
- There’s a Word for “Views Differ” When One View Is The State - March 24th, 2010 [March 24th, 2010]
- Association for Molecular Pathology, et al. v. USPTO, et al. – Opinion - March 29th, 2010 [March 29th, 2010]
- Birth of a Super Villain - April 3rd, 2010 [April 3rd, 2010]
- “Medical Products” like 23andMe must not become the new “Financial Products” - April 4th, 2010 [April 4th, 2010]
- How I Would Apply Genomic Technology In Clinical Use Today - April 5th, 2010 [April 5th, 2010]
- Gmail Enterprise: World’s Best EMR - April 6th, 2010 [April 6th, 2010]
- Brief Primer on Health Law Compliance - April 9th, 2010 [April 9th, 2010]
- Spoiler: You ARE the “Valids” - April 9th, 2010 [April 9th, 2010]
- Rachel Lehmann-Haupt Line by Line Take Down - April 9th, 2010 [April 9th, 2010]
- Is Medicare Bankrupt? What the Hell Is Going On? - April 17th, 2010 [April 17th, 2010]
- The Big Shuffle: Medicare Cuts Rates by 21.3% (but not “technically”) - April 17th, 2010 [April 17th, 2010]
- “Tech Hiring Binge” == “Fear for Your Job, Nerds” - April 18th, 2010 [April 18th, 2010]
- How Bad is Bad? $.20 on the Private Medical Insurance Dollar - April 20th, 2010 [April 20th, 2010]
- Update: How Bad is Bad? It Used to Be $.45 on the Medical Insurance Dollar - April 20th, 2010 [April 20th, 2010]
- World’s Best “EMR” for $1000: Google Spreadsheets + iPad - April 21st, 2010 [April 21st, 2010]
- Don’t Insult Me with your “AOL Keyword” Strategy, Google Health - April 21st, 2010 [April 21st, 2010]
- How to Play LAWGAMES - April 23rd, 2010 [April 23rd, 2010]
- Top 4 Predatory Schemes Encroaching on American Medicine: Part 1 - April 25th, 2010 [April 25th, 2010]
- What’s the Big Deal About iPads? - April 27th, 2010 [April 27th, 2010]
- Got Google Android for Google I/O - April 27th, 2010 [April 27th, 2010]
- Google Enterprise meets HIPAA and HITECH Compliant Laws - April 29th, 2010 [April 29th, 2010]
- Pixels of Accuracy CHALENGE: Diagnostic Medical Imaging - April 29th, 2010 [April 29th, 2010]
- 23andMe Launder AlioGenetics Doesn’t Even Bother to Remove 23andMe Logo - April 30th, 2010 [April 30th, 2010]
- Anthem of CT Denies $600 Until “Subscriber Responds to our Coordination of Benefits Questionnaire” - May 1st, 2010 [May 1st, 2010]
- Apple And Google Team Up To Launch Revolutionary Mobile Health System - May 1st, 2010 [May 1st, 2010]
- Funny Pictures from This Year Building the Medical Practice - May 6th, 2010 [May 6th, 2010]
- Remote Medical Video Monitoring on iPad and iPhone - May 7th, 2010 [May 7th, 2010]
- Google Calendar Overhead Waiting Room Display - May 7th, 2010 [May 7th, 2010]
- Various Whiteboards on Solid State Medical Operations - May 7th, 2010 [May 7th, 2010]
- The Raw Facts about Counsyl - May 7th, 2010 [May 7th, 2010]
- Brawndo: Still Mutilating Thirst, Still Not Yet Sold at the Stop-n-Shop Pharmacy - May 9th, 2010 [May 9th, 2010]
- Video: Google Enterprise to Outsource Medical Administration - May 9th, 2010 [May 9th, 2010]
- Gattaca: “The Matrix” of Genomics - May 11th, 2010 [May 11th, 2010]
- 23andMe Now Diagnoses Fatal Tay-Sachs Disease - May 12th, 2010 [May 12th, 2010]
- Why Was Pathway Targeted for FDA Enforcement and Not 23andMe? - May 15th, 2010 [May 15th, 2010]
- John Dolan on Aging and the Horrifying Conclusion of GWAS - May 16th, 2010 [May 16th, 2010]
- Sam R. Riley Wants To Tell You About Practice Fusion - May 17th, 2010 [May 17th, 2010]
- Response to “Genomic Medicine: Lost” - May 19th, 2010 [May 19th, 2010]
- Death And Taxes: CMS to IRS - May 19th, 2010 [May 19th, 2010]
- Please Stop Antagonizing the AMA - May 26th, 2010 [May 26th, 2010]
- Dan Vorhaus, Attorney At Law, Legally Advises Medical Doctors Can Use 23andMe To Provide Medical Advice - May 28th, 2010 [May 28th, 2010]
- Singularity Summit 2010 in San Francisco to Explore Intelligence Augmentation - June 7th, 2010 [June 7th, 2010]
- OpenPCR: DNA amplification for anyone - June 10th, 2010 [June 10th, 2010]
- FDA sends letters to 5 genetic testing companies - June 11th, 2010 [June 11th, 2010]
- Amazon And The NIH Team Up To Put Human Genome In The Cloud - March 31st, 2012 [March 31st, 2012]
- ReproSource Comments on New Study Linking Infertility to Genetics - April 25th, 2012 [April 25th, 2012]
- Genetics 101 Part 1: What are genes? - Video - April 30th, 2012 [April 30th, 2012]
- Red Ice Radio - David Icke - Hour 1 - The Manipulation of Humanity - Video - April 30th, 2012 [April 30th, 2012]
- Genetics Part 5: Human Genetic Disorders - Video - April 30th, 2012 [April 30th, 2012]
- C2CAM - The Nephilim, Genetic Manipulation - April 30th, 2012 [April 30th, 2012]
- Human Nature talk with Robert Sapolsky, Gabor Mate, James Gilligan, Richard Wilkinson - Video - April 30th, 2012 [April 30th, 2012]
- Human Genetic Diseases - Video - April 30th, 2012 [April 30th, 2012]
- Alien Scientist on Genetics, Implants - April 30th, 2012 [April 30th, 2012]
- Research and Markets: Genetics, 6th Edition International Student Version Continues To Educate Today's Students for ... - May 4th, 2012 [May 4th, 2012]
- Myriad Genetics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference - May 4th, 2012 [May 4th, 2012]
- Genetics may explain some people's dislike of meat - May 4th, 2012 [May 4th, 2012]
- 'Blond Genes' May Vary Around the World - May 4th, 2012 [May 4th, 2012]